6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)

6.3 Scheduled Listed Chemical Products (SLCPs) & Combat Methamphetamine Epidemic Act (CMEA)

MPJE Core Concept: The Combat Methamphetamine Epidemic Act (CMEA) of 2005 (enacted as Title VII of the USA PATRIOT Improvement and Reauthorization Act) created a regulatory category known as Scheduled Listed Chemical Products (SLCPs) to restrict retail access to precursor chemicals used in the illicit clandestine manufacturing of methamphetamine.

---

Definition of Scheduled Listed Chemical Products (SLCPs)

Under 21 U.S.C. § 802(45), an SLCP is defined as any non-prescription drug product that contains any of the following active precursor chemicals:

1. Ephedrine
2. Pseudoephedrine (PSE)
3. Phenylpropanolamine (PPA) (Note: PPA is restricted to veterinary prescription use or specialized chemical use in humans due to stroke risk, but remains statutorily listed under CMEA).

SLCPs include all non-prescription dosage forms (tablets, capsules, liquids, dual-actives, and pediatric syrups) containing these chemicals.

---

Statutorily Mandated Purchase Limits (Base Chemical Weight)

Critical MPJE Distinguishing Rule: Salt Weight vs. Base Chemical Weight

All CMEA statutory sales caps are strictly calculated based on the weight of the pure free base chemical, NOT the overall product or salt weight!

• Calculation Example: Pseudoephedrine Hydrochloride (PSE HCl) contains approximately 82.2% pseudoephedrine base. A 30 mg PSE HCl tablet contains approximately 24.6 mg of pure base. Therefore, 120 tablets of 30 mg PSE HCl equal 3.6 grams of PSE HCl salt, but only 2.95 grams of pure pseudoephedrine base.

Statutory Sales Limits (21 U.S.C. § 830)

Packaging Requirements

Non-liquid SLCP forms (tablets or capsules) must be packaged in unit-dose blister packs, with each blister containing not more than 2 dosage units, or unit-dose pouches when blister packaging is technologically infeasible.

---

Storage & Behind-the-Counter (BTC) Controls

To prevent direct customer access and shoplifting, retail sellers must store all SLCPs in one of two secure locations:

1. Behind the Prescription Counter (BTC): In an area restricted solely to pharmacy employees; OR
2. Locked Display Cabinet: In a locked case located on the retail sales floor, where customers must request an employee to unlock the cabinet to retrieve the product.

---

Purchaser Verification & Logbook Mandates

Required Identification

Before completing an OTC SLCP sale, the retail clerk or pharmacist must verify a government-issued photo ID (driver's license, state ID, passport, or military ID) confirming that the purchaser's name matches the logbook entry.

Logbook Record Entries

Retail sellers must maintain a written or electronic logbook recording the following mandatory data points for every SLCP transaction:

1. Purchaser's signature (written or electronic signature pad).
2. Purchaser's printed name.
3. Purchaser's residential address.
4. Date and time of the transaction.
5. Name of the product and total quantity sold (expressed in grams of base).

National Precursor Log Exchange (NPLEx)

Most states enforce participation in NPLEx, a real-time electronic logging system administered by the National Association of Drug Diversion Investigators (NADDI). NPLEx connects retail chain pharmacies across state lines, automatically cross-referencing purchaser IDs in real time and blocking transactions at point-of-sale if a purchaser attempts to exceed daily (3.6 g) or 30-day (9.0 g) base limits across multiple retail locations.

The 60 mg Single Package Logbook Exemption

Under 21 U.S.C. § 830(e)(1)(A)(iii), federal law provides a specific exemption for small convenience sales:

Single Sales Exemption: Any single OTC transaction involving a package containing not more than 60 mg of pseudoephedrine (e.g., a package containing two 30 mg tablets or one 60 mg tablet) is EXEMPT from the logbook entry, purchaser signature, and photo ID verification requirements.

---

Recordkeeping & Logbook Retention

Logbook records (written or electronic) documenting SLCP sales must be safely retained for a minimum of 2 years (24 months) from the date of the transaction.

Confidentiality Provisions

Logbook information is strictly confidential. Retailers may not disclose logbook data for commercial marketing purposes. Logbook records may be accessed and inspected only by authorized law enforcement officials (DEA, state police, local law enforcement) for legitimate anti-methamphetamine enforcement or compliance auditing.

---

Mandatory DEA Self-Certification & Employee Training

Annual Self-Certification

Every retail seller of SLCPs must complete an annual self-certification with the DEA via the DEA online registration portal. The seller certifies that:

1. All employees interacting with SLCP sales have received mandatory CMEA compliance training.
2. Training records and employee rosters are maintained on site.
3. Sales limits, packaging, storage, and logbook protocols are strictly enforced.

Employee Training Mandate

Retail sellers must train all employees on CMEA regulations, ID verification, sales limits, and logbook requirements before allowing them to sell SLCPs. A signed employee training acknowledgment must be placed in the pharmacy's compliance records.